NeoGenomics, Inc. announced that Chief Strategy and Corporate Development Officer, Douglas Brown will be leaving the Company on May 27th to pursue other interests. Chief Financial Officer, William Bonello, and Chief Culture Officer, Jennifer Balliet, will continue to serve in their current roles.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.44 USD | -2.30% | -4.56% | -10.75% |
02/05 | North American Morning Briefing : Stock Futures -3- | DJ |
30/04 | Needham Lowers Price Target on NeoGenomics to $19 From $24 Due to Peer Multiple Compression, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.75% | 184.42Cr | |
-20.70% | 783.02Cr | |
+67.01% | 429.02Cr | |
+0.14% | 257.93Cr | |
-8.58% | 247.66Cr | |
-38.69% | 246.25Cr | |
-19.84% | 153.24Cr | |
-40.24% | 121.74Cr | |
+16.56% | 120.34Cr | |
+14.92% | 96Cr |
- Stock Market
- Equities
- NEO Stock
- News NeoGenomics, Inc.
- NeoGenomics, Inc. Announces Resignation of Douglas Brown as Chief Strategy and Corporate Development Officer